Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and Melanoma

Eur Urol. 2015 Nov;68(5):754-5. doi: 10.1016/j.eururo.2015.07.023. Epub 2015 Jul 31.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Erectile Dysfunction / drug therapy*
  • Humans
  • Kallikreins / blood*
  • Male
  • Neoplasm Recurrence, Local / epidemiology*
  • Phosphodiesterase 5 Inhibitors / therapeutic use*
  • Postoperative Complications / drug therapy*
  • Prostate-Specific Antigen / blood*
  • Prostatectomy*
  • Prostatic Neoplasms / surgery*

Substances

  • Phosphodiesterase 5 Inhibitors
  • Kallikreins
  • kallikrein-related peptidase 3, human
  • Prostate-Specific Antigen